Relapsed acute myeloid leukemia: why is there no standard of care?

  title={Relapsed acute myeloid leukemia: why is there no standard of care?},
  author={Farhad Ravandi},
  journal={Best practice & research. Clinical haematology},
  volume={26 3},
Relapse after achieving a prior response remains one of the most important obstacles to improving the outcome of patients with acute myeloid leukemia (AML). Although overall, the majority of patients with disease relapse do poorly, this is by no means uniform and a number of predictors of outcome have been identified. Previously, most trials of investigational agents in the setting of disease relapse in AML have accrued a wide range of patients with widely different patient and disease… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-10 of 12 extracted citations

Similar Papers

Loading similar papers…